Cabergoline 0.5 MG

DRUG6 trials

Sponsors

Boston Children's Hospital, University of Aarhus, Al-Rasheed University College, National Taiwan University Hospital, Aarhus University Hospital

Conditions

EndometriosisMRIMigrainePCOSPituitary AdenomaPolycystic Ovary SyndromeRCT

Phase 2

Cabergoline for the Treatment of Chronic Pain Due to Endometriosis

CompletedNCT03928288

Boston Children's HospitalEndometriosis

Start: 2019-12-02End: 2026-01-14Updated: 2026-01-28

Effects of Combined Metformin and Cabergoline in Comparison With Metformin Only Therapy on Ovarian and Hormonal Activities in Iraqi Patients With PCOS

CompletedNCT05981742

Al-Rasheed University CollegePolycystic Ovary Syndrome

Start: 2022-09-21End: 2023-03-31Updated: 2023-08-08

Cabergoline for Episodic Migraine

RecruitingNCT07072910

Aarhus University HospitalMigraine

Start: 2025-11-12End: 2028-09-01Target: 150Updated: 2025-11-18

Phase 4

Cabergoline in the Management of Nonfunctioning Pituitary Adenoma

Enrolling by invitationNCT07034859

National Taiwan University HospitalMRI, Pituitary Adenoma, RCT

Start: 2024-05-20End: 2028-12-31Target: 30Updated: 2025-06-24

Unknown Phase

Cabergoline as a Preventive Treatment for Chronic Migraine

CompletedNCT05525611

University of AarhusMigraine

Start: 2022-09-05End: 2023-08-08Updated: 2024-02-26

Cabergoline & Letrozole Versus Letrozole in Ovulation Induction in PCOS

RecruitingNCT07255911

Mst.Sumyara KhatunPCOS

Start: 2025-02-07End: 2026-06-30Target: 72Updated: 2025-12-16

Related Papers

Cabergoline as a preventive migraine treatment: A randomized clinical pilot trial

PLoS ONE2025-04-012 citations

Study protocol.

OPAL (Open@LaTrobe) (La Trobe University)2025-04-01

CONSORT checklist.

OPAL (Open@LaTrobe) (La Trobe University)2025-04-01